952675-00-2

Upstream product

• 952674-99-6 2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazole-5-sulfonyl chloride 
• 35344-95-7 1H-pyrazole-4-carbaldehyde 
• 364-76-1 4-Fluoro-3-nitroaniline 
• 881413-61-2 N-(3-Amino-4-{[(4,4-difluorocyclohexyl)methyl]amino}phenyl)acetamide 
• 881413-60-1 N-(4-{[(4,4-Difluorocyclohexyl)methyl]amino}-3-nitrophenyl)acetamide 
• 881413-63-4 2-tert-Butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-amine 
• 809273-65-2 (4,4-difluorocyclohexane)methylamine hydrochloride 
• 809273-64-1 tert-butyl (4,4-difluorocyclohexyl)methylcarbamate 
• 809273-70-9 (4-oxo-cyclohexylmethyl)-carbamic acid tert-butyl ester 
• 351-32-6 N-(4-fluoro-3-nitrophenyl)acetamide 

Downstream Products

• 952675-01-3 1-({2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-1H-benzimidazol-5-yl}sulfonyl)-1H-pyrazole-4-carboxylic acid 

Relevant academic research and scientific papers

Therapeutic Compounds

Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.

Therapeutic Compounds

Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3 and R4 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.